Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


Tyndall and Sanmina have announced a research collaboration, which will focus on the development of a novel wireless technology for a commercial wrist-worn health-monitoring platform. This platform will wirelessly monitor heart rate and arterial oxygen saturation (SpO2). Led by the Wireless Sensors Network (WSN) group at Tyndall, the objective of this research partnership is to improve the performance of these wearable platforms by providing more energy efficient wireless communications when compared with existing technology. The project is being funded by Enterprise Ireland through their Innovation Partnership Programme.

Read more ...

Abaxis, is a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, announced that the USDA, Center for Veterinary Biologics, approved its new VetScan FLEX4 Rapid Test for veterinary use. The FLEX4 is a 4-in-1 lateral flow test used for the qualitative detection of Heartworm antigen as well as antibodies for Lyme, Ehrlichia and Anaplasma in canine whole blood, serum, or plasma samples.

Read more ...

Flu Results in as Little as 20 Minutes. Cepheid announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for the Xpert Xpress Flu test. The test can be performed in near-patient settings, providing rapid and accurate molecular detection of Flu A and B RNA from patient specimens, in as little as 20 minutes.

Read more ...

Amoy Diagnostics announced that China Food and Drug Administration (CFDA) approved its Super-ARMS EGFR Mutation Test for use with plasma samples, as a companion diagnostic for non-small cell lung cancer (NSCLC) therapy with EGFR-TKIs on January 19. It is the first companion diagnostic kit approved by CFDA for the detection of the epidermal growth factor receptor (EGFR) gene mutations in circulating tumor DNA (ctDNA) derived from plasma. Patients with NSCLC carrying EGFR activating mutations, such as exon 19 deletions, L858R mutation, or T790M mutation, are candidates for the EGFR-targeted therapy with EGFR-TKIs.

Read more ...

Check-Cap (the "Company" or "Check-Cap"), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, announced it has received CE Mark approval for the C-Scan system.

Read more ...

Two Pore Guys (2PG) announced that it is collaborating with Maxim Integrated Products, on a series of analog signal processing technologies for 2PG's solid-state nanopore diagnostic testing platform. As part of this collaboration, Maxim has invested in 2PG through its venture arm Maxim Ventures.

Read more ...

Upcoming Events

> Medisens
(February 26 - February 27, London, UK)

> CRISPR & precision genome editing
(February 28 - February 28, Boston, USA)

> Medical Wearables 2018
(May 16 - May 17, Santa Clara, California)


No events


BioMEMS, the next big thing for MEMS players ?
Discover the presentation held by Sébastien Clerc at MEMS & Sensors Executive Congress, in ...
Status of the Microfluidics Industry
Discover the presentation held by Sébastien Clerc at Sensor China Conference of September 1...
Status of the Microfluidics Industry
Discover the presentation held by Benjamin Roussel at EAC Annual Conference 2017, in Singap...

Access to all our presentations